Donor cell expansion is delayed following nonablative in utero transplantation to treat murine mucopolysaccharidosis type VII

Experimental Hematology

Volumn 31, Issue 11, 2003, Pages 1112-1118

  Barker, Jane E ^a   Schuldt, Adam J T ^a   Lessard, Mark L ^a   Jude, Craig D ^a   Vogler, Carole A ^b   Soper, Brian W ^a  

^a JACKSON LABORATORY   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLUCURONIDASE; GLYCOSAMINOGLYCAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD DONOR; CELL COUNT; CELL FATE; CELL TRANSPLANTATION; CHILDHOOD DISEASE; CONTROLLED STUDY; ENZYME ANALYSIS; FEMALE; FETUS; FLOW CYTOMETRY; HISTOCHEMISTRY; HISTOPATHOLOGY; MALE; MOUSE; MUCOPOLYSACCHARIDOSIS TYPE 7; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECIPIENT; STEM CELL; STORAGE DISEASE; TISSUE SECTION; UTERUS;

MURINAE;

EID: 0142258090     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(03)00234-0     Document Type: Article

References (28)

1. Flake A.W., Roncarolo M.G., Puck J.M., et al. Treatment of X-linked severe combined immunodeficiency by in utero transplantation of paternal bone marrow. N Engl J Med. 335:1996;1806-1810.
2. Wengler G.S., Lanfranchi A., Frusca T., et al. In-utero transplantation of parental CD34 haematopoietic progenitor cells in a patient with X-linked severe combined immunodeficiency (SCIDXI). Lancet. 348:1996;1484-1487.
3. Touraine J.L., Raudrant D., Laplace S., Gebuhrer L. Stem cell transplants in utero for genetic diseases: treatment and a model for induction of immunologic tolerance. Transplant Proc. 31:1999;681-682.
4. Shields L.E., Lindton B., Andrews R.G., Westgren M. Fetal hematopoietic stem cell transplantation: a challenge for the twenty-first century. J Hematother Stem Cell Res. 11:2002;616-631.
5. Blazar B.R., Taylor P.A., Vallera D.A. In utero transfer of adult bone marrow cells into recipients with severe combined immunodeficiency disorder yields lymphoid progeny with T- and B-cell functional capabilities. Blood. 86:1995;4353-4366.
6. Donahue J., Gilpin E., Young D., Carrier E. Postnatal cytokines and boosts improve chimerism and hematological parameters in beta-thalassemic mice transplanted in utero. Transplantation. 71:2001;1491-1494.
7. Casal M.L., Wolfe J.H. In utero transplantation of fetal liver cells in the mucopolysaccharidosis type VII mouse results in low-level chimerism, but overexpression of β-glucuronidase can delay onset of clinical signs. Blood. 97:2001;1625-1634.
8. Fleischman R.A., Mintz B. Development of adult bone marrow stem cells in H-2-compatible and -incompatible mouse fetuses. J Exp Med. 159:1984;731-745.
9. Shaaban A.F., Kim H.B., Milner R., Flake A.W. A kinetic model for the homing and migration of prenatally transplanted marrow. Blood. 94:1999;3251-3257.
10. Howson-Jan K., Matloub Y.H., Vallera D.A., Blazar B.R. In utero engraftment of fully H-2-incompatible versus congenic adult bone marrow transferred into nonanemic or anemic murine fetal recipients. Transplantation. 56:1993;709-716.
11. Barker J.E., Schuldt A.J., Lessard M.L., Jude C.M., Vogler C.A., Soper B.W. Donor cell repopulation in mice transplanted in utero is limited by immune-independent mechanisms. Blood Cells Mol Dis. 31:2003;291-297.
12. Barker J.E., Deveau S., Lessard M., Hamblen N., Vogler C., Levy B. In utero fetal liver cell transplantation without toxic irradiation alleviates lysosomal storage in mucopolysaccharidosis type VII. Blood Cells Mol Dis. 27:2001;861-873.
13. Blazar B.R., Taylor P.A., Vallera D.A. Adult bone marrow-derived pluripotent hematopoietic stem cells are engraftable when transferred in utero into moderately anemic fetal recipients. Blood. 85:1995;833-841.
14. Zanjani E.D., Ascensao J.L., Tavassoli M. Liver-derived fetal hematopoietic stem cells selectively and preferentially home to the fetal bone marrow. Blood. 81:1993;399-404.
15. Cowan M.J., Tarantal A.F., Capper J., Harrison M., Garovoy M. Long term engraftment following in utero T cell-depleted parental marrow transplantation into fetal rhesus monkeys. Bone Marrow Transplant. 17:1996;1156-1165.
16. Hayashi S., Peranteau W.H., Shaaban A.F., Flake A.W. Complete allogeneic hematopoietic chimerism achieved by a combined strategy of in utero hematopoietic stem cell transplantation and postnatal donor lymphocyte infusion. Blood. 100:2002;804-812.
17. Soper B.W., Lessard M.D., Vogler C.A., et al. Non-ablative neonatal marrow transplantation attenuates functional and physical defects of β-glucuronidase deficiency. Blood. 97:2001;1498-1504.
18. Wolfe J.H., Sands M.S. Murine mucopolysaccharidosis type VII: a model system for somatic gene therapy of the central nervous system. Lowenstein P.R., Enquist L.W. Protocols for Gene Transfer in Neurological Disorders. 1996;263-274 Wiley, Chichester.
19. Vogler C., Birkenmeier E.H., Sly W.S., et al. A murine model of mucopolysaccharidosis VII: gross and microscopic findings in beta-glucuronidase-deficient mice. Am J Pathol. 136:1990;206-217.
20. Birkenmeier E.H., Barker J.E., Vogler C.A., et al. Increased life span and correction of metabolic defects in murine mucopolysaccharidosis type VII after syngeneic bone marrow transplantation. Blood. 78:1991;3081-3092.
21. Soper B.W., Duffy T.M., Vogler C.A., Barker J.E. A genetically myeloablated MPS VII model detects the expansion and curative properties of as few as 100 enriched murine stem cells. Exp Hematol. 27:1999;1691-1704.
22. Andreani M., Manna M., Lucarelli G., et al. Persistence of mixed chimerism in patients transplanted for the treatment of thalassemia. Blood. 87:1996;3494-3499.
23. Persons D.A., Allay E.R., Sabatino D.E., Kelly P., Bodine D.M., Nienhuis A.W. Functional requirements for phenotypic correction of murine beta-thalassemia: implications for human gene therapy. Blood. 97:2001;3275-3282.
24. Wolfe J., Sands M.S., Barker J.E., et al. Reversal of pathology in murine mucopolysaccharidosis type VII by somatic cell gene transfer. Nature. 360:1992;749-753.
25. Vogler C., Levy B., Galvin N.J., et al. Enzyme replacement in murine mucopolysaccharidosis type VII: neuronal and glial response to beta glucuronidase requires early initiation of enzyme replacement therapy. Pediatr Res. 45:1999;838-844.
26. Hoskins A.A., Vogler C., Creer M.H., Sands M.S. Engraftment of human CD34+ cells leads to widespread distribution of donor-derived cells and correction of tissue pathology in a novel murine xenotransplantation model of lysosomal storage disease. Blood. 101:2003;2054-2063.
27. Barker J.E., Kaysser-Kranich T.M., Hamblen N., Deveau S. Multiple high cell dose injections of normal marrow into newborn jaundiced mice dramatically prolong life despite transient repopulation. Exp Hematol. 27:1999;966-971.
28. Peranteau W.H., Hayashi S., Hsieh M., Shaaban A.F., Flake A.W. High-level allogeneic chimerism achieved by prenatal tolerance induction and postnatal nonmyeloablative bone marrow transplantation. Blood. 100:2002;2225-2234.